Ramat Gan, Israel – March 1, 2009 – EarlySense, developer of the Everon® patient supervision system for hospital and home use, announced today a collaboration with Catholic Healthcare West (CHW), the eighth largest hospital system in the nation and the largest not-for-profit hospital provider in California, to test Everon in the hospital setting.
Select hospitals within the 41-hospital CHW system are slated to evaluate the impact of EverOn both clinically and financially to determine whether and how best to implement the technology. Based on evaluation outcomes, certain CHW facilities may elect to be training centers for the EverOn system.
EverOn is a wireless patient supervision system installed underneath the hospital bed mattress. There are no leads or cuffs to connect to the patient, who has complete freedom of movement and is not burdened by any irritating attachments. The system measures patient vital signs and movements and alerts nurses of any change in condition. EverOn detects heart and respiration rates, bed entries and exits, as well as patient movement and turns. EverOn also helps medical staff to better implement patient turns, which can positively influence the treatment and the prevention of pressure ulcers. EverOn’s trend line display is designed to assist clinicians in monitoring the progression of a patient’s health. At present, the system is for investigational use only.
“We are combining the strengths of a leading hospital system with those of a medical device innovator to facilitate the introduction of EverOn in the U.S. We believe this structure has great value as it will ultimately provide both clinical and financial benefits,” said Dr. Yehuda Zicherman, V.P. of Marketing at EarlySense.
CHW and EarlySense also announced today that California Hospital Medical Center in Los Angeles will be the first CHW clinical site to trial EverOn. Mark Meyers, president of California Hospital Medical Center, said, “There is a clear, present and immediate need for an innovative, high tech system that can automatically, and without imposing upon patient comfort, track movement and vital signs and warn of possible life threatening situations. We are pleased to be evaluating the EverOn system to determine how it can help us in our ongoing work of delivering excellent, compassionate care.”
“We are delighted and honored to partner with CHW, a well respected and notable hospital network, and its experienced and professional team at California Hospital Medical Center. We hope to together achieve the goal of improving healthcare and securing better outcomes for patients and their caregivers,” said Avner Halperin, CEO of EarlySense.
Catholic Healthcare West (CHW), headquartered in San Francisco, CA, is a system of 41 hospitals and medical centers in California, Arizona and Nevada. Founded in 1986, it is eighth largest health system in the nation and the largest not-for-profit provider in California. CHW is committed to delivering compassionate, high-quality, affordable health care services with special attention to the poor and underserved. The CHW network of nearly 10,000 physicians and approximately 53,000 employees provides health care services to more than five million people annually. In 2008, CHW provided $967 million in charity care and unsponsored community benefit. For more information, please visit our website at www.chwHEALTH.org.
Conveniently located in the heart of downtown Los Angeles 2 blocks from the Staples Center, California Hospital Medical Center is a 316-bed acute care hospital known for its wide range of specialties, from Orthopedics and Surgery to Maternity and Neonatal Intensive Care. It is also the area’s only Level II Trauma Center.
EarlySense is bringing to market a pioneering technology designed to advance proactive and preventive patient supervision to enable better patient outcomes. The company’s flagship product, EverOn, is an automatic, continuous, contact-free patient supervision device that follows and documents a patient’s vital signs and movement. The system is currently being clinically evaluated at several medical centers. EarlySense is headquartered in Ramat-Gan, Israel.